ARROWHEAD PHARMACEUTICALS, INC. (ARWR) /
The debt of ARROWHEAD PHARMACEUTICALS, INC. over the past 10 years
Chart ARROWHEAD PHARMACEUTICALS, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2024, ARROWHEAD PHARMACEUTICALS, INC. had liquid cash of $578.28M and total debt of $393.18M: net cash of $185.09M. It had more liquid cash than debt at all 8 year-ends shown. Total debt was highest at the end of fiscal 2024 ($393.18M) and lowest at the end of fiscal 2019 ($0). No net cash figure is on file for fiscal 2023 and 2025.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Sep 30, 2025 | $692.82M | — | — |
| 2024ended Sep 30, 2024 | $578.28M | $393.18M | $185.09M |
| 2023ended Sep 30, 2023 | $292.74M | — | — |
| 2022ended Sep 30, 2022 | $268.39M* | $0 | $268.39M |
| 2021ended Sep 30, 2021 | $183.35M* | $0 | $183.35M |
| 2020ended Sep 30, 2020 | $315.49M* | $0 | $315.49M |
| 2019ended Sep 30, 2019 | $258.7M* | $0 | $258.7M |
| 2018ended Sep 30, 2018 | $76.53M* | $2.33M | $74.21M |
| 2017ended Sep 30, 2017 | $65.61M* | $2.53M | $63.07M |
| 2016ended Sep 30, 2016 | $85.37M | $2.73M | $82.64M |
Fiscal years as ARROWHEAD PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ARROWHEAD PHARMACEUTICALS, INC.
- The revenue of ARROWHEAD PHARMACEUTICALS, INC.
- The profitability of ARROWHEAD PHARMACEUTICALS, INC.
- The cash flow of ARROWHEAD PHARMACEUTICALS, INC.
- All of ARROWHEAD PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- VICRVICOR CORPORATION
- ADCAGREE REALTY CORPORATION
- OSKOshkosh Corporation
- WLKWestlake Corporation
- CTVACorteva, Inc.
Not investment advice. This page shows what ARROWHEAD PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.